Personalized SBRT in Early-Stage Peripheral NSCLC

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

August 4, 2023

Primary Completion Date

March 1, 2029

Study Completion Date

March 1, 2029

Conditions
Early-stage Peripheral Non-small Cell Lung Cancer
Interventions
DEVICE

ndividualized Stereotactic Body Radiotherapy (SBRT) System

The individualized SBRT system employs advanced image-guided radiation delivery to deliver highly conformal, ablative doses to early-stage peripheral non-small-cell lung cancer while minimizing exposure to surrounding normal tissues. Treatment is delivered via a state-of-the-art robotic radiosurgery platform (e.g., CyberKnife M6) according to patient-specific fractionation schedules based on tumor size and proximity to critical structures, following standard indications and institutional protocols for medically inoperable or surgically refused cases.

Trial Locations (2)

300381

Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060, Tianjin

Unknown

Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Cancer Institute and Hospital

OTHER